The majority shareholder in enzyme supplier Novozymes has acquired PAI Partners’ 25% stake in Denmark-based food ingredients group Chr. Hansen.

Privately-owned Novo said on Wednesday (11 January) that it had agreed to buy PAI’s interest in Chr Hansen for around EUR560m (US$718.4m).

Go deeper with GlobalData

Go deeper with GlobalData

The gold standard of business intelligence.

Find out more

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

Novo said it did not intend to take control of Chr. Hansen but was “excited” to support the company as a “long-term minority shareholder”.

“Chr. Hansen is a well-run company and is a good fit with our investment strategy, and we believe that it will prove to be an attractive long-term investment for us,” Novo CEO Henrik Gürtler said.

PAI acquired Chr. Hansen, which makes food ingredients for manufacturers in the dairy, confectionery and meat sectors, in 2005.

The private-equity firm kept a majority stake in Chr. Hansen when the company listed in 2010 but has since reduced its shareholding.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Just Food Excellence Awards - Nominations Closed

Nominations are now closed for the Just Food Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact.

Excellence in Action
Winning five categories in the 2025 Just Food Excellence Awards, Centric Software is setting the pace for digital transformation in food and FMCG. Explore how its integrated PLM and PXM suite delivers faster launches, smarter compliance and data-driven growth for complex, multi-channel product portfolios.

Discover the Impact